The Horizons Medical Marijuana Life Sciences ETF will begin trading on April 5, 2017 TORONTO, March 28, 2017 /CNW/ - Horizons ETFs Management (Canada) Inc. ("Horizons ETFs") is pleased to announce that it has filed its final prospectus to launch the Horizons Medical Marijuana Life Sciences ETF ("HMMJ"). Units of the exchange traded fund ("ETF") have been conditionally approved for listing by the Toronto Stock Exchange ("TSX") and are slated to begin trading on April 5, 2017, under the ticker symbol HMMJ. HMMJ will be the first ETF that offers direct exposure to North American-listed stocks that are involved with medical marijuana bioengineering and production. HMMJ is an index (or passively managed) ETF, which seeks to replicate, to the extent possible, the performance of the North American Medical Marijuana Index ("the Index"), net of expenses. The Index is designed to provide exposure to the performance of a basket of North American publicly traded companies with significant business activities in the marijuana industry.
